Kymera TherapeuticsKYMR

那斯達克 · USD
115.50
-3.89
(-3.26%)
盤中 11/21 01:27 (UTC+8)
11/21 01:27 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.26
  • 0.04
  • 0.07
  • 0.22
  • 0.11
  • 0.03
  • 0.03
  • 0.34
  • 0.65
  • -
icon
  • 149.34
  • -85.42
  • 97.65
  • 198.89
  • -48.07
  • -75.91
  • 3.80
  • 1097.39
  • 89.15
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q3
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
營業收入淨額
-
65,000
34,365
2,870
2,765
11,476
22,100
7,394
3,741
25,650
營業成本
----------
營業毛利
-
65,000
34,365
2,870
2,765
11,476
22,100
7,394
3,741
25,650
營業費用
147,231140,609118,519100,76695,28596,03396,52688,14975,86576,575
研發費用
128,508119,48298,16283,83174,09478,38880,25571,81760,41059,202
推銷及管理費用
18,72321,12720,35716,93517,33617,64516,27116,33215,45517,373
非經常性項目費用
----3,855-----
其他營業費用
----------
營業利益
-147,231
-75,609
-84,154
-97,896
-92,520
-84,557
-74,426
-80,755
-72,124
-50,925
其他收入及費用
15,29414,47814,98111,00510,4458,0518,91710,0629,6968,925
利息費用
6280619010010872595962
稅前純益
-131,999
-61,211
-69,234
-86,981
-82,175
-76,614
-65,581
-70,752
-62,487
-42,062
所得稅
----------
稅後純益
-131,999
-61,211
-69,234
-86,981
-82,175
-76,614
-65,581
-70,752
-62,487
-42,062
基本每股稅後盈餘(元)
-1.32-0.62-0.71-0.97-0.94-0.95-0.82-0.88-0.82-0.58
稀釋每股稅後盈餘(元)
-1.33-0.62-0.71-0.98-0.94-0.95-0.82-0.89-0.83-0.57
基本平均股數(千股)
100097.0098177.0097534.0089914.0087300.0080449.0080146.0079987.0076125.0073059.00
稀釋平均股數(千股)
100097.0098177.0097534.0089914.0087300.0080449.0080146.0079987.0076125.0073059.00
還原基本每股稅後盈餘(元)
-1.32-0.62-0.71-0.97-0.94-0.95-0.82-0.88-0.82-0.58
還原稀釋每股稅後盈餘(元)
-1.33-0.62-0.71-0.98-0.94-0.95-0.82-0.89-0.83-0.57
還原基本平均股數(千股)
100,09798,17797,53489,91487,30080,44980,14679,98776,12573,059
還原稀釋平均股數(千股)
100,09798,17797,53489,91487,30080,44980,14679,98776,12573,059
EBITDA(千元)
-129,914-59,101-67,151-84,859-79,926-74,422-63,461-68,706-60,441-40,062

大家都在看

HOT